Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA; Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators. Teoh H, et al. Among authors: langer a. Am J Cardiol. 2009 Sep 15;104(6):798-804. doi: 10.1016/j.amjcard.2009.05.019. Epub 2009 Jul 23. Am J Cardiol. 2009. PMID: 19733714
Contemporary management of dyslipidemia in high-risk patients: targets still not met.
Yan AT, Yan RT, Tan M, Hackam DG, Leblanc KL, Kertland H, Tsang JL, Jaffer S, Kates ML, Leiter LA, Fitchett DH, Langer A, Goodman SG; Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators. Yan AT, et al. Among authors: langer a. Am J Med. 2006 Aug;119(8):676-83. doi: 10.1016/j.amjmed.2005.11.015. Am J Med. 2006. PMID: 16887414
Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
Tsang JL, Mendelsohn A, Tan MK, Hackam DG, Leiter LA, Fitchett D, Lin PJ, Grima E, Langer A, Goodman SG; Vascular Protection Registry and Guidelines Oriented Approach to Lipid Lowering Registry Investigators. Tsang JL, et al. Among authors: langer a. Am J Cardiol. 2008 Nov 1;102(9):1142-5. doi: 10.1016/j.amjcard.2008.06.037. Epub 2008 Aug 15. Am J Cardiol. 2008. PMID: 18940280
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.
Braga M, Casanova A, Teoh H, Dawson KC, Gerstein HC, Fitchett DH, Harris SB, Honos G, McFarlane PA, Steele A, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events (DRIVE) Investigators. Braga M, et al. Among authors: langer a. Can J Cardiol. 2010 Jun-Jul;26(6):297-302. doi: 10.1016/s0828-282x(10)70393-7. Can J Cardiol. 2010. PMID: 20548975 Free PMC article.
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
Bhan V, Yan RT, Leiter LA, Fitchett DH, Langer A, Lonn E, Tan M, Silagy S, Goodman SG, Yan AT; Guidelines Oriented Approach in Lipid Lowering (GOALL) Registry and Vascular Protection (VP) Registry Investigators. Bhan V, et al. Among authors: langer a. Am J Cardiol. 2010 Nov 1;106(9):1270-6. doi: 10.1016/j.amjcard.2010.06.055. Am J Cardiol. 2010. PMID: 21029823
Use of a treatment optimization algorithm involving statin-ezetimibe combination aids in achievement of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC).
Katz PM, Mendelsohn AA, Goodman SG, Langer A, Teoh H, Leiter LA. Katz PM, et al. Among authors: langer a. Can J Cardiol. 2011 Mar-Apr;27(2):138-45. doi: 10.1016/j.cjca.2010.12.010. Can J Cardiol. 2011. PMID: 21459260
836 results